Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis
Authors:
- Yun-Hua LuYLYun-Hua Lu
- Jing-Hang XieJXJing-Hang Xie
- Fen WangFWFen Wang
- Jia-Ning ZouJZJia-Ning Zou
- Jia-Sen YangJYJia-Sen Yang
- Ying-Ying XingYXYing-Ying Xing
- Tao XiTXTao Xi
- 1 April 2009
- journal article
- case report
- Published by Wolters Kluwer Health in Anti-Cancer Drugs
- Vol. 20 (4) , 249-258
Abstract
Ursolic acid (UA), a naturally occurring pentacyclic triterpene, is a potent in-vitro anticancer agent, acting through control of growth, apoptosis and differentiation. As the mechanism of its proapoptotic effects on human hepatocellular carcinoma cells has not been extensively studied, we performed an in depth evaluation of the effects of UA on apoptosis in human HepG2 cells. UA was found to inhibit the proliferation of HepG2 cells in a concentration and time-dependent manner. After treatment, cells showed evidence of activation of apoptosis, including the presence of apoptotic bodies and DNA fragmentation. UA-induced apoptosis was accompanied by a significant decrease in bcl-2 and survivin expression, with the corresponding ratio of bax/bcl-2 increased. The treatment with UA also increased the protein level and enzymatic activity of caspase-3. Z-DEVD-fmk, a specific caspase-3 inhibitor, significantly inhibited both the cytotoxic effect and the DNA fragmentation induced by UA, demonstrating the requirement for caspase-3 activity in UA-induced apoptosis. Inactivation of the phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway was also involved, as inhibition of PI3K by LY294002 significantly increased UA-induced apoptosis. Kinetic experiments indicated that UA downregulated PI3K/p85 subunit (PI3K/p85) and phospho-Akt, before downregulating survivin. The further results also confirmed that LY294002 not only downregulated survivin alone, but considerably enhanced the repression of survivin combined with UA. UA therefore seemed to downregulate the expression of survivin by blocking PI3K/Akt. Taken together, the data suggest that the proapoptotic effect of UA on HepG2 cells is mediated by activation of caspase-3, and is highly correlated with inactivation of PI3K/Akt/survivin pathway.Keywords
This publication has 30 references indexed in Scilit:
- Ursolic acid induces apoptosis by activating p53 and caspase-3 gene expressions and suppressing NF-κB mediated activation of bcl-2 in B16F-10 melanoma cellsInternational Immunopharmacology, 2008
- Induction of Apoptosis and Regulation of the MAPK Pathway by Ursolic Acid in Human Leukemia K562 CellsPlanta Medica, 2007
- Oleanolic acid and ursolic acid: Research perspectivesJournal of Ethnopharmacology, 2005
- Ursolic acid induces Bax-dependent apoptosis through the caspase-3 pathway in endometrial cancer SNG-II cellsOncology Reports, 2005
- Primary liver cancer: Worldwide incidence and trendsGastroenterology, 2004
- Proliferative inhibition, cell-cycle dysregulation, and induction of apoptosis by ursolic acid in human non-small cell lung cancer A549 cellsLife Sciences, 2004
- Effects of ursolic acid on different steps of the angiogenic processBiochemical and Biophysical Research Communications, 2004
- Cyclic Adenosine Monophosphate Inhibits Ursolic Acid-Induced Apoptosis via Activation of Protein Kinase A in Human Leukaemic HL-60 CellsBasic & Clinical Pharmacology & Toxicology, 2000
- Inhibitory effect of ursolic acid on B16 proliferation through cell cycle arrestCancer Letters, 1996
- Pharmacology of oleanolic acid and ursolic acidJournal of Ethnopharmacology, 1995